Riibotics to Showcase "Brownfield Robotics" at RoboBusiness 2025
Autonomous forklifts retrofit existing warehouses with no infrastructure changes, delivering ROI in under one year
Defining a New Category: Brownfield Robotics
Riibotics is pioneering a new category of automation it calls "brownfield robotics." Unlike "greenfield" automation, which requires new robot-ready facilities, Riibotics' solutions retrofit into legacy environments. Leveraging advanced AI and perception, Riibotics forklifts navigate autonomously through unstructured and dynamic spaces, handling materials that are randomly placed or unorganized.
"Most industrial facilities can't afford to rebuild their operations for automation," said
Proven in Real-World Operations
Riibotics has already validated its approach through a commercial project with a Tier 1 automotive supplier. In a congested, human-shared environment, Riibotics forklifts transported materials from the production line to the warehouse—without requiring magnetic tapes, QR codes, or other infrastructure. Using advanced perception, the system autonomously detected randomly placed materials, located empty storage slots, and completed fully hands-off material handling. The project delivered a payback period of less than one year, and the customer is now expanding deployment after seeing safe, efficient collaboration between humans and robots.
Strategic Push into the U.S. Market
RoboBusiness marks the start of Riibotics' strategic expansion into the
About Riibotics
Riibotics is a deep-tech robotics company developing full-stack autonomous robotic forklift technology to enhance productivity and safety in complex industrial environments. The company is backed by the Deep-tech TIPS (Tech Incubator Program for Startups) grant and has earned top honors at major startup competitions, including Try Everything and the KDB Startup Program.
View original content to download multimedia:https://www.prnewswire.com/news-releases/riibotics-to-showcase-brownfield-robotics-at-robobusiness-2025-302573356.html
SOURCE Riibotics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
- IBM Study: Sports Fans Want Streamlined Digital Experiences as Platform Choices Expand
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share